L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-25 4:05 pm Purchase |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 21,050 7.590% |
7,200 (+51.99%) |
Filing |
| 2025-04-25 4:01 pm Purchase |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 13,850 4.990% |
3,850 (+38.50%) |
Filing |
| 2025-04-07 4:51 pm Purchase |
2025-04-02 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 10,000 6.210% |
10,000 (New Position) |
Filing |